Inspire Investing LLC Decreases Holdings In Intuitive Surgical By 2.0% In Q1
July 14, 2023
☀️Trending News
Intuitive Surgical ($NASDAQ:ISRG), Inc. is an American multinational medical device company that designs, manufactures and markets robotic surgical systems. The company’s da Vinci Surgical System is the most advanced of its type in the world. It uses computer-assisted robotics to facilitate complex surgeries by providing surgeons with a 3D HD view into the patient’s body.
Inspire Investing LLC, a private investment firm, has recently reduced its stake in Intuitive Surgical, Inc. by 2.0%, according to its most recent 13F filing to the SEC. The decrease in the stake indicates that Inspire Investing LLC may not be as confident in the future prospects of Intuitive Surgical as it was before.
Analysis
GoodWhale conducted an analysis of INTUITIVE SURGICAL‘s wellbeing and found that it is a medium risk investment in terms of financial and business aspects. After conducting our Risk Rating assessment, we have detected 3 risk warnings in income sheet, balance sheet, non financial. In order to view these risk warnings, you will need to become a registered user. Our analysis can provide you with an overview of the company’s potential risks, enabling you to make an informed decision when investing. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Intuitive Surgical. More…
Total Revenues | Net Income | Net Margin |
6.43k | 1.31k | 20.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Intuitive Surgical. More…
Operations | Investing | Financing |
1.49k | 1.37k | -2.57k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Intuitive Surgical. More…
Total Assets | Total Liabilities | Book Value Per Share |
13.05k | 1.76k | 31.55 |
Key Ratios Snapshot
Some of the financial key ratios for Intuitive Surgical are shown below. More…
3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
11.8% | 3.5% | 24.2% |
FCF Margin | ROE | ROA |
14.9% | 8.8% | 7.5% |
Peers
The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.
– Stryker Corp ($NYSE:SYK)
With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.
– Medtronic PLC ($NYSE:MDT)
Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.
– Becton, Dickinson and Co ($NYSE:BDX)
Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.
Summary
Intuitive Surgical, Inc. is a medical device company that manufactures robotic-assisted surgical systems. As a result, investors interested in the stock should conduct a thorough analysis of the company’s financials and competitive position to determine if it is still a viable long-term investment opportunity.
Recent Posts